HCA
OPRX icon

Harbor Capital Advisors’s OptimizeRx OPRX Stock Holding History

Harbor Capital Advisors’s Portfolio OPRX Stock Details OPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-24,876
Closed -$305K – 1420
2025
Q4 		$305K Buy
24,876
+2,708
+12% +$44.2K 0.02% 577
2025
Q3 		$454K Buy
+22,168
New +$352K 0.04% 504

Other funds holding OPRX

WCA
Whetstone Capital Advisors Shawnee Mission, Kansas $288M AUM 44.06% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
PHP
Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Harbor Capital Advisors's OPRX Position: Q1 2026 in Review

Harbor Capital Advisors sold out of OptimizeRx (OPRX) in Q1 2026, closing a stake of 24,876 shares — an estimated $305K sold.

Harbor Capital Advisors first reported a position in OPRX in Q3 2025 and held it in 2 quarters. The position peaked at $454K in Q3 2025. 127 funds tracked by Wall St. Rank hold OPRX as of Q1 2026.

  • Harbor Capital Advisors reported no remaining OptimizeRx position as of Q1 2026 after selling out during the quarter.
  • Harbor Capital Advisors sold 24,876 OptimizeRx shares in Q1 2026, an estimated $305K.
  • Harbor Capital Advisors first reported a position in OptimizeRx in Q3 2025 and held it in 2 quarters.
  • Harbor Capital Advisors's OptimizeRx position peaked at $454K in Q3 2025.
  • 127 funds tracked by Wall St. Rank held OptimizeRx as of Q1 2026.

Based on Harbor Capital Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.